m+Medelevator.RU
← Поиск публикаций
Advanced materials (Deerfield Beach, Fla.) · 2025

Spinal Cord-Like Scaffold with Rapid Tissue Integration Enhanced Spinal Cord Nerve Repair.

СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Bai Baoshuai, Zhang Ruizhi, Zhang Chi, Liu Yanhan, Liu Shuo, Zou Chenbo, Jiang Linlin, Qi Zhangyang, Song Xingqi, Li Chunlin, Li Zhen, Wu Kailin, Song Yijie, Hou Mengfan, Li Chao, Zhou Guangdong, Kong Xiaohong, Lei Dong, Zhou Hengxing, Feng Shiqing

Аннотация

Spinal cord injury (SCI) repair represents an immense challenge globally. Despite various beneficial strategies having been attempted for SCI repair, the ideal therapy has not yet been achieved. In this study, a multidimensional biomimetic spinal cord-like scaffold (MBSLS) is designed with a hierarchical structure and embryonic neurogenetic microenvironment and neural regeneration in SCI repair. MBSLS successfully regulated the neural differentiation of loaded neural stem cells (NSCs) and regenerated spinal cord-like tissue in vitro by promoting neurogenesis, gliogenesis, axonogenesis, axon ensheathment, synapse organization, and calcium homeostasis. Moreover, the NSC-loaded scaffold achieves exceptional SCI repair through highly efficient axonal regeneration and neural circuit reconstruction, which significantly improves the recovery of motor function, sensory function, and autonomic function in vivo. Importantly, the MBSLS scaffold achieves seamless integration with the host spinal cord in only 5 min, allowing early cell infiltration and repair. Finally, the feasibility of the minimally invasive implantation of human-sized MBSLS in a pig SCI model is confirmed, demonstrating its potential and prospects for clinical translation to treat SCI.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты